The company is substantially advanced its course of an new therapy for ATTR-CM, utilizing the investigational drug. Preliminary clinical results reveals promising benefits for individuals suffering with a severe https://biotech118941.blogzet.com/firm-improves-amyloidosis-treatment-using-the-drug-57257378